Aclaris Therapeutics Inc. (ACRS)
2.50
0.02 (0.81%)
At close: Jan 14, 2025, 3:59 PM
2.57
3.01%
Pre-market Jan 15, 2025, 08:46 AM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| Net Income | -88.48M | -86.91M | -90.86M | -51.02M | -161.35M | -132.74M | -68.52M | -48.08M | -20.56M | -8.52M | -5.24M |
| Depreciation & Amortization | 863.00K | 797.00K | 923.00K | 1.32M | 6.41M | 1.88M | 402.00K | 120.00K | 90.00K | 12.00K | 11.00K |
| Stock-Based Compensation | 20.54M | 15.04M | 14.06M | 11.21M | 16.18M | 20.05M | 14.43M | 6.10M | 891.00K | 27.00K | n/a |
| Other Working Capital | 10.68M | -1.70M | -5.15M | -2.04M | 661.00K | 6.75M | -3.70M | 2.44M | -712.00K | 22.00K | -1K |
| Other Non-Cash Items | -20.27M | 4.70M | 24.34M | 2.39M | 734.00K | 555.00K | 10.67M | 2.78M | -5.00K | 1K | 3.00K |
| Deferred Income Tax | -367.00K | n/a | 752.00K | -182.00K | 44.29M | n/a | -1.84M | 216.00K | 289.00K | n/a | n/a |
| Change in Working Capital | 9.39M | -1.20M | -1.34M | -2.36M | -2.70M | 9.44M | 865.00K | 4.25M | -1.07M | 841.00K | 302.00K |
| Operating Cash Flow | -78.33M | -67.57M | -52.13M | -38.63M | -96.44M | -100.81M | -54.66M | -34.60M | -20.37M | -7.64M | -4.92M |
| Capital Expenditures | -1.31M | -605.00K | -308.00K | -453.00K | -1.61M | -1.36M | -1.24M | -232.00K | -507.00K | -417.00K | n/a |
| Acquisitions | n/a | -13.23M | 167.32M | -6.84M | 34.19M | -67.12M | -9.65M | n/a | n/a | n/a | n/a |
| Purchase of Investments | -135.68M | -164.75M | -235.15M | -47.71M | -137.38M | -161.60M | -197.34M | -148.76M | -82.51M | -5.04M | -4.54M |
| Sales Maturities Of Investments | 183.20M | 177.99M | 67.83M | 54.55M | 210.49M | 239.44M | 152.53M | 87.09M | 6.07M | 3.67M | n/a |
| Other Investing Acitivies | n/a | 13.23M | -167.32M | 6.84M | 34.19M | 77.84M | -44.81M | -61.67M | -76.44M | -1.36M | -4.54M |
| Investing Cash Flow | 46.22M | 12.63M | -167.63M | 6.39M | 105.68M | 9.37M | -55.69M | -61.90M | -76.95M | -1.78M | -4.54M |
| Debt Repayment | n/a | n/a | -11.48M | 10.78M | -30.52M | 29.26M | -78.00K | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 86.00K | 123.00K | -1.67M | 7.60M | 207.00K | -1.21M | 235.00K | 121.00K | 39.86M | 10.58M | n/a |
| Financial Cash Flow | 26.71M | 72.87M | 225.05M | 18.37M | -30.32M | 128.26M | 100.39M | 116.83M | 96.41M | 10.58M | n/a |
| Net Cash Flow | -5.40M | 17.93M | 5.29M | -13.87M | -21.08M | 36.82M | -9.97M | 20.32M | -906.00K | 1.17M | -9.46M |
| Free Cash Flow | -79.63M | -68.17M | -52.44M | -39.09M | -98.06M | -102.17M | -55.90M | -34.84M | -20.88M | -8.05M | -4.92M |